Mamianetti A, Labonia N A, Lafont D, Fiordalisi H H
Acta Gastroenterol Latinoam. 1982;12(1):33-8.
22 patients with radiolucid stones and functioning gallbladder were grouped to establish ursodeoxycholic acid efficacy (i.e. gallstones dissolution) and innocuousness for gallbladder lithiasis. Methodological aspects were detailed, the dose determined (8 and 10 mg/k/d.) and the patients evaluated after a six months' treatment. 11 patients received "day-time" doses and the other 11 "overnight" dose. Only 7 subjects turned out to be evaluated for the study of biliary lipids, to the other 15 the development of their gallstones was followed up. Successful gallstone dissolution was achieved in 8 patients (53,3%), 2 reduced size and number. 5 out of these 8 patients received "day-time" doses and the other 3 "overnight" doses. From an attendance point of view, we do not consider biliary lipids study (bile cholesterol saturation rate) to be necessary.
22例患有透X线结石且胆囊功能正常的患者被分组,以确定熊去氧胆酸对胆囊结石的疗效(即胆结石溶解)及安全性。详细阐述了方法学方面的内容,确定了剂量(8和10毫克/千克/天),并在六个月的治疗后对患者进行评估。11例患者接受“日间”剂量,另外11例接受“夜间”剂量。只有7名受试者接受了胆汁脂质研究评估,另外15名患者则对其胆结石的发展进行了随访。8例患者(53.3%)胆结石成功溶解,2例结石大小和数量减少。这8例患者中,5例接受“日间”剂量,另外3例接受“夜间”剂量。从随访角度来看,我们认为没有必要进行胆汁脂质研究(胆汁胆固醇饱和率)。